Cephalexin remains the preferred antibiotic for uncomplicated cellulitis: Revisited

Journal of Chemotherapy

Volumn 26, Issue 2, 2014, Pages 65-66

  Cunha, Burke A ^a,b  

^a WINTHROP UNIVERSITY HOSPITAL   (United States)

^b Department of Psychiatry   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFALEXIN; CEPHALOSPORIN; COTRIMOXAZOLE; DOXYCYCLINE; PANTON VALENTINE LEUKOCIDIN; ANTIINFECTIVE AGENT;

CELLULITIS; CHILL; CLINICAL FEATURE; EDITORIAL; FEVER; HUMAN; LYMPHANGITIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; NONHUMAN; SKIN ABSCESS; STREPTOCOCCUS INFECTION; DRUG EFFECTS; ISOLATION AND PURIFICATION; MICROBIOLOGY; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; CELLULITIS; CEPHALEXIN; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 84895825950     PISSN: 1120009X     EISSN: 19739478     Source Type: Journal    
DOI: 10.1179/1973947814Y.0000000170     Document Type: Editorial

References (10)

1. Pallin DJ, Binder WD, Allen MB, Lederman M, Parmar S, Filbin M, et al. Clinical trial: comparative effectiveness of cephalexin plus trimethoprim-sulfamethoxazole versus cephalexin alone for treatment of uncomplicated cellulitis: a randomized controlled trial. Clin Infect Dis. 2013;56:1754-62.
2. Cunha BA. Methicillin-resistant S. aureus: clinical manifestations and antimicrobial therapy. Clin Microbiol Infect. 2005;4:33-42.
3. Cenizal MJ, Skiest D, Luber S, Bedimo R, Davis P, Fox P, et al. Prospective randomized trial of empiric therapy with trimethoprim-sulfamethoxazole of doxycycline for outpatient skin and soft tissue infections in an area of high prevalence of methicillinresistant S. aureus. Antimicrob Agents Chemother. 2007;51: 2628-30.
4. DeAngelis G, Cipriani M, Cauda R, Tacconelli E. Treatment of skin and soft tissue infections due to community-associated methicillin-resistant S. aureus in Europe: the role of trimethoprim-sulfamethoxazole. Clin Infect Dis. 2011;52:1471-2.
5. Cunha BA. Oral antibiotic treatment of MRSA infections. J Hosp Infect. 2005;60:88-90.
6. Proctor RA. Role of folate antagonists in the treatment of methicillin-resistant S. aureus infection. Clin Infect Dis. 2008;46:584-93.
7. Perez A, Orta L, Pascual M, Padilla E, Mesquida X, Gonzalez M, et al. Management of mild CA-MRSA skin infections: more complicated that it looks at a glance. Eur J Dermatol. 2012;22:800-1.
8. Cunha BA. Antibiotic resistance: effective control strategies. Lancet. 2001;357:1307-8.
9. Szumowski JD, Cohen DE, Kanaya F, Mayer KH. Treatment outcomes of infections by methicillin-resistant S. aureus at an ambulatory clinic. Antimicrob Agents Chemother. 2007;51:423-8.
10. Cunha BA. Cephalexin remains preferred oral antibiotic therapy for uncomplicated cellulitis. Am J Med. 2008;11:e13.